nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cells
|
Giri, Shibashish |
|
2015 |
20 |
1 |
p. 37-49 13 p. |
artikel |
2 |
An analysis of FDA-approved drugs for pain and anesthesia
|
Kinch, Michael S. |
|
2015 |
20 |
1 |
p. 3-6 4 p. |
artikel |
3 |
Can agricultural fungicides accelerate the discovery of human antifungal drugs?
|
Myung, Kyung |
|
2015 |
20 |
1 |
p. 7-10 4 p. |
artikel |
4 |
Contents page 2
|
|
|
2015 |
20 |
1 |
p. iii- 1 p. |
artikel |
5 |
Contents page 1
|
|
|
2015 |
20 |
1 |
p. i- 1 p. |
artikel |
6 |
Delivering a disease-modifying treatment for Huntington's disease
|
Godinho, Bruno M.D.C. |
|
2015 |
20 |
1 |
p. 50-64 15 p. |
artikel |
7 |
Designing novel building blocks is an overlooked strategy to improve compound quality
|
Goldberg, Frederick W. |
|
2015 |
20 |
1 |
p. 11-17 7 p. |
artikel |
8 |
Drug hunters incorporated! Is there a formula?
|
Bennani, Youssef L. |
|
2015 |
20 |
1 |
p. 1-2 2 p. |
artikel |
9 |
Evolutions in fragment-based drug design: the deconstruction–reconstruction approach
|
Chen, Haijun |
|
2015 |
20 |
1 |
p. 105-113 9 p. |
artikel |
10 |
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives
|
Pandita, Deepti |
|
2015 |
20 |
1 |
p. 95-104 10 p. |
artikel |
11 |
Individualized dosing of tyrosine kinase inhibitors: are we there yet?
|
de Wit, Djoeke |
|
2015 |
20 |
1 |
p. 18-36 19 p. |
artikel |
12 |
Is there a link between selectivity and binding thermodynamics profiles?
|
Tarcsay, Ákos |
|
2015 |
20 |
1 |
p. 86-94 9 p. |
artikel |
13 |
Microbial amphiphiles: a class of promising new-generation anticancer agents
|
Dey, Goutam |
|
2015 |
20 |
1 |
p. 136-146 11 p. |
artikel |
14 |
Neuroprotective agents target molecular mechanisms of disease in ALS
|
Zhu, Yongjin |
|
2015 |
20 |
1 |
p. 65-75 11 p. |
artikel |
15 |
Peptide therapeutics: current status and future directions
|
Fosgerau, Keld |
|
2015 |
20 |
1 |
p. 122-128 7 p. |
artikel |
16 |
Role of beta-blockers in patients with COPD: current perspective
|
Malerba, Mario |
|
2015 |
20 |
1 |
p. 129-135 7 p. |
artikel |
17 |
Slit/Robo pathway: a promising therapeutic target for cancer
|
Gara, Rishi K. |
|
2015 |
20 |
1 |
p. 156-164 9 p. |
artikel |
18 |
Therapeutic applications of the cell-penetrating HIV-1 Tat peptide
|
Rizzuti, Mafalda |
|
2015 |
20 |
1 |
p. 76-85 10 p. |
artikel |
19 |
Trypanosomatids see the light: recent advances in bioimaging research
|
Calvo-Álvarez, Estefanía |
|
2015 |
20 |
1 |
p. 114-121 8 p. |
artikel |
20 |
Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
|
Vater, Axel |
|
2015 |
20 |
1 |
p. 147-155 9 p. |
artikel |